3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
32
Pain, Postoperative
18
Neoplasms
15
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Lung Neoplasms
12
Brain Neoplasms
12
Prostatic Neoplasms
9
Ovarian Neoplasms
8
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Stomach Neoplasms
7
Depression
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Pain
6
Head and Neck Neoplasms
6
Thyroid Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leiomyoma
5
Agnosia
5
Neoplasm Metastasis
4
Lymphoma
4
Fatigue
4
Delirium
4
Anxiety Disorders
4
Urinary Bladder Neoplasms
3
Thromboembolism
3
Supratentorial Neoplasms
3
Stomatitis
3
Interventions
Indocyanine Green
2
Ileostomy
2
Bioseal
2
Water
1
Tobramycin
1
Tissue Adhesives
1
Surgical Procedures, Operative
1
Surgical Fixation Devices
1
Somatostatin
1
Sodium Chloride
1
Serum Albumin, Human
1
Saline Solution
1
Robotic Surgical Procedures
1
Neomycin
1
Metronidazole
1
Methods
1
Levofloxacin
1
Inulin
1
Fluorescein Angiography
1
Fibrin Tissue Adhesive
1
Esophagectomy
1
Enoxaparin
1
Endoscopy
1
Enbucrilate
1
Diet
1
Congresses as Topic
1
Colistin
1
Ciprofloxacin
1
Cathartics
1
Amphotericin B
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anastomotic Leak
×
Saline Solution
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn